NoNO Inc.

2 in Phase 3

Quick facts

Phase 3 pipeline

Nerinetide (NA-1) · Neurology
Nerinetide is a peptide that inhibits postsynaptic density protein 95 (PSD-95) to reduce excitotoxic neuronal death following ischemic stroke.
NoNO-42
NoNO-42 is a nitric oxide (NO) donor compound designed to increase nitric oxide bioavailability in target tissues.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: